Search results
Results From The WOW.Com Content Network
Takeda Midosuji Building, headquarters of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan. Takeda Pharmaceuticals was founded in 1781, and was incorporated on January 29, 1925. [ 12] One of the firm's mainstay drugs is Actos ( pioglitazone ), a compound in the thiazolidinedione class of drugs used in the treatment of type 2 diabetes.
Retrieved 2 June 2024. ^ "Bajrang Aur Ali trailer released – a heartwarming tale of friendship and unity". The Times of India. 25 May 2024. ISSN 0971-8257. Retrieved 2 June 2024. ^ "Blackout FIRST POSTER: Vikrant Massey and Mouni Roy starrer thriller to release on THIS date". Pinkvilla. 17 May 2024.
Animal was initially set for an 11 August 2023 release, but was postponed due to post-production and dubbing work, as well as to avoid clashing with Jailer, Gadar 2 and Oh My God 2. [65] It was theatrically released on 1 December 2023 in standard and IMAX formats in Hindi with dubbed versions in Telugu, Tamil, Malayalam and Kannada languages. [66]
BENGALURU (Reuters) -Japan's Takeda Pharmaceutical is holding talks with Indian regulators to make its dengue vaccine available in the country, the drugmaker's global head of vaccines, Gary Dubin ...
On Thursday, Japan’s drugmaker Takeda Pharmaceutical Company Limited (NYSE:TAK) announced a restructuring after the company reported a fiscal year 2023 net profit of 144 billion yen (around $954 ...
Takeda's treatment will be available in stick packs of 2 milligram doses by the end of February, the company said. The company has set wholesale acquisition cost for the therapy, given twice daily ...
The teaser for Stree 2 premiered in theatres during the end credits of Munjya on 14 June, and was later released on social media on 25 June 2024. [26] [27] The trailer of the film was released on 18 July 2024 and received over 10 crore views across platforms within 24 hours. [28] [29]
TOKYO (Reuters) -Japan's biggest drugmaker Takeda Pharmaceutical on Thursday slashed its full-year profit forecast by 36% as it contends with disappointments in its development pipeline and the ...